Occurrence of antidepressants – from wastewater to drinking water

• Autorzy: Rezka P. , Balcerzak W.

Identyfikatory

DOI

10.4467/2353737XCT.16.204.5953

Warianty tytułu

PL

Występowanie leków przeciwdepresyjnych – ze ścieków do wody uzdatnionej

• Języki publikacji: EN

Abstrakty

EN

The article’s subject is the presence of antidepressants in the wastewater and aquatic environment. The basic characteristics of selected antidepressants were presented. A review of the literature on the occurrence of these compounds in sewage influents and effluents, surface waters and sludge was made. As a general rule, drinking water should be free of any organic, especially pharmaceutical, contaminants. But according to data, the presence of antidepressants in source water for water purification plants poses a threat to their penetration to the water supply system and, eventually, to consumers of water intended for human consumption.

PL

W artykule omówiono zagadnienie występowania leków przeciwdepresyjnych w ściekach i środowisku wodnym. Dokonano przeglądu literatury dotyczącej występowania tych związków w ściekach surowych i oczyszczonych oraz wodach powierzchniowych, a także w osadach z oczyszczalni. Jak wynika z danych literaturowych, obecność antydepresantów w wodzie surowej ujmowanej przez stacje uzdatniania wody stwarza realne zagrożenie dla systemów wodociągowych, a w następstwie dla odbiorców wody przeznaczonej do spożycia.

Słowa kluczowe

EN

Selective Serotonin Reuptake Inhibitors; SSRI; wastewater; surface water; drinking water; sewage sludge

PL

selektywne inhibitory zwrotnego wychwytu serotoniny; ścieki; wody powierzchniowe; wody; woda do picia; osady ściekowe

• Wydawca: Wydawnictwo Politechniki Krakowskiej im. Tadeusza Kościuszki
• Czasopismo: Czasopismo Techniczne. Środowisko
• Rocznik: 2016
• Tom: Y. 113, iss. 1-Ś
• Strony: 145--155
• Opis fizyczny: Bibliogr. 53 poz., tab., il.

Twórcy

autor

Rezka P.

• Institute of Water Supply and Environmental Protection, Faculty of Environmental Engineering, Cracow University of Technology

autor

Balcerzak W.

• Institute of Water Supply and Environmental Protection, Faculty of Environmental Engineering, Cracow University of Technology

Bibliografia

• [1] Alonso S.G., Catala M., Maroto R.R., Rodriguez J.L.G., Miguel A.G., Valvarcel Y., Pollution by psychoactive pharmaceuticals in the rivers of Madrid metropolitan area (Spain), Environment International, Vol. 36, 2010, 195–201.
• [2] Arlos M.J., Bragg L.M., Parker W.J., Servos M.R., Distribution of selected antiandrogens and pharmaceuticals in a highly impacted watershed, Water Research, Vol. 72, 2015, 40–50.
• [3] Baker D.R., Kasprzyk-Hordern B., Multi-residue analysis of drugs of abuse in wastewater and surface water by solid-phase extraction and liquid chromatography-positive electrospray ionization tandem mass spectrometry, Journal of Chromatography A, Vol. 1218, 2011, 1620–1631.
• [4] Baker D.R., Kasprzyk-Hordern B., Spatial and temporal occurrence of pharmaceuticals and illicit drugs in the aqueous environment and during wastewater treatment: New developments, Science of the Total Environment, Vol. 454-455, 2013, 442–456.
• [5] Balcerzak W., Rezka P., Occurrence of anti–cancer drugs in the aquatic environment and efficiency of their removal – the selected issues, Technical Transactions, vol. 1–Ś/2014, 11–18.
• [6] Barnes K.K., Kolpin D.W., Furlong E.T., Zaugg S.D., Meyer M.T., Barber L.B., A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States-I) Groundwater, Science of the Total Environment, Vol. 402, 2008, 192–200.
• [7] Batt A.L., Kostich M.S., Lazorchak J.M., Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UPLC/MS/MS, Analytical Chemistry, Vol. 80, 2008, 5021–5030.
• [8] Benotti M.J., Trenholm R.A., Vanderford B.J., Holady J.C., Stanford B.D., Snyder S.A., Pharmaceuticals and endocrine disrupting compunds in U.S. drinking water, Environmental Science and Technology, Vol. 43, 2009, 597–603.
• [9] Brooks B.W., Chambliss C.K., Stanley J.K., Ramirez A., Banks K.E., Johnson R.D., Lewis R.J., Determination of select antidepressants in fish from an effluent-dominated stream, Environmental Toxicology and Chemistry, Vol. 24, 2005, 464–469.
• [10] Bueno M.J.M., Aguera A., Gomez M.J., Hernando M.D., Reyes J.F.G., Alba A.R.F., Application of liquid chromatography/quadrupole-linear ion trap mass spectrometry and time-of-flight mass spectrometry to the determination of pharmaceuticals and related contaminants in wastewater, Analytical Chemistry, Vol. 79, 2007, 9372–84.
• [11] Caracciolo A.B., Topp E., Grenni P., Pharmaceuticals in the environment: Biodegradation and effects on natural microbial communities. A review, Journal of Pharmaceutical and Biomedical Analysis, Vol. 106, 2015, 25–36.
• [12] Chu S., Metcalfe C.D., Analysis of paroxetine, fluoxetine and norfluoxetine in fish tissues using pressurized liquid extraction, mixed mode solid phase extraction cleanup and liquid chromatography-tandem mass spectrometry, Journal of Chromatography A, Vol. 1163, 2007, 112–118.
• [13] Drugbank database (http://www.drugbank.ca) – online 27.04.2016.
• [14] Evans S.E., Davies P., Lubben A., Kasprzyk-Hordern B., Determination of chiral pharmaceuticals and illicit drugs in wastewater and sludge using microwave assisted extraction, solid-phase extraction and chiral liquid chromatography coupled with tandem mass spectrometry, Analytica Chimica Acta, Vol. 882, 2015, 112–126.
• [15] Fernandez C., Gonzalez-Doncel M., Pro J., Carbonell G., Tarazona J.V., Occurrence of pharmaceutically active compounds in surface waters of the Henares-Jarama-Tajo river system (Madrid, Spain) and a potential risk characterization, Science of the Total Environment, Vol. 408, 2010, 543–551.
• [16] Fick J., Soderstrom H., Lindberg R.H., Phan C., Tysklind M., Larsson D.G.J., Contamination of surface ground and drinking water from pharmaceutical production, Environmental Toxicology and Chemistry, Vol. 28, 2009, 2522–2527.
• [17] Gardner M., Jones V., Comber S., Scrimshaw M.D., Coello-Garcia T., Cartmell E., Lester J., Ellor B., Performance of UK wastewater treatment works with respect to trace contaminants, Science of the Total Environment, Vol. 456-457, 2013, 359–369.
• [18] Giebułtowicz J., Nałęcz-Jawecki G., Occurrence of antidepressant residues in the sewage-impacted Vistula and Utrata rivers and in tap water in Warsaw (Poland), Ecotoxicology and Environmental Safety, Vol. 104, 2014, 103–109.
• [19] Golovko O., Kumar V., Fedorova G., Randak T., Grabic R., Seasonal changes in antibiotics, antidepressants/psychiatric drugs, antihistamines and lipid regulators in a wastewater treatment plant, Chemosphere, Vol. 111, 2014, 418–426.
• [20] Gonzalez-Rey M., Tapie N., Le Menach K., Devier M.-H., Budzinski H., Bebianno M.J., Occurrence of pharmaceutical compounds and pesticides in aquatic systems, Marine Pollution Bulletin, Vol. 96 (1–2), 2015, 384–400.
• [21] Gracia-Lor E., Sancho J.V., Serrano R., Hernandez F., Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia, Chemosphere, Vol. 87, 2012, 453–462.
• [22] Gros M., Petrovic M., Barcelo D., Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching, Analytical Chemistry, Vol. 81, 2009, 898–912.
• [23] Huerta-Fontela M., Galceran M.T., Ventura F., Occurrence and removal of pharmaceuticals and hormones through drinking water treatment, Water Research, Vol. 45, 2011, 1432–1442.
• [24] Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J., The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impacts on the quality of receiving waters, Water Research, Vol. 43, 2009, 363–380.
• [25] Kim S.D., Cho J., Kim I.S., Vanderford B.J., Snyder S.A., Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking and waste waters, Water Research, Vol. 41, 2007, 1013–1021.
• [26] Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T., Pharmaceuticals, hormones and other organic wastewater contaminants in US streams, 1999–2000: a national reconnaissance, Environmental Science and Technology, Vol. 36, 2002, 1202–1211.
• [27] Lajeunesse A., Gagnon C., Sauve S., Determination of basic antidepressants and their N-desmethyl metabolites in raw sewage and wastewater using solid-phase extraction and liquid chromatography-tandem mass spectrometry, Analytical Chemistry, Vol. 80, 2008, 5325–5333.
• [28] Lajuenesse A., Smyth S.A., Barclay K., Sauve S., Gagnon C., Distribution of antidepressant residues in wastewater and biosolids following different treatment processes by municipal wastewater treatment plants in Canada, Water Research, Vol. 46, 2012, 5600–5612.
• [29] MacLeod S.L., Sudhir P., Wong C.S., Stereoisomer analysis of wastewater-derived β-blockers, selective serotonin re-uptake inhibitors and salbutamol by high-performance liquid chromatography-tandem mass spectrometry, Journal of Chromatography A, Vol. 1170, 2007, 23–33.
• [30] Metcalfe C.D., Chu S., Judt C., Li H., Ken D.O., Servos M.R., Andrews D.M., Antidepressants and their metabolites in municipal wastewater and downstream exposure in an urban watershed, Environmental Toxicology and Chemistry, Vol. 29, 2010, 79–89.
• [31] Metcalfe C.D., Miao X.S., Koenig B.G., Struger J., Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada, Environmental Toxicology and Chemistry, Vol. 22, 2003, 2881–2889.
• [32] Mompelat S., Le Bot B., Thomas O., Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water, Environment International, Vol. 35, 2009, 803–814.
• [33] Petrie B., Barden R., Kasprzyk-Hordern B., A review on emerging contaminants in wastewaters and the environment: Current knowledge, understudied areas and recommendations for future monitoring, Water Research, Vol. 72, 2015, 3–27.
• [34] Salgado R., Marques R., Noronha J.P., Mexia J.T., Carvalho G., Oehmen A., Reis M.A.M., Assessing the diurnal variability of pharmaceutical and personal care products in a full-scale activated sludge plant, Environmental Pollution, Vol. 159, 2011, 2359–2367.
• [35] Schlusener M.P., Hardenbicker P., Nilson E., Schulz M., Viergutz C., Ternes T.A., Occurrence of venlafaxine, other antidepressants and selected metabolites in the Rhine catchment in the face of climate change, Environmental Pollution, Vol. 196, 2015, 247–256.
• [36] Schultz M.M., Furlong E.T., Trace analysis of antidepressant pharmaceuticals and their select degradates in aquatic matrixes by LC/ESI/MS/MS, Analytical Chemistry, Vol. 80, 2008, 1756–1762.
• [37] Schultz M.M., Furlong E.T., Kolpin D.W., Werner S.L., Schoenfuss H.L., Barber L.B., Blazer V.S., Norris D.O., Vajda A.M., Antidepressant pharmaceuticals in two U.S. effluent-impacted streams: occurrence and fate in water and sediment and selective uptake in fish neural tissue, Environmental Science and Technology, Vol. 44, 2010, 1918–1925.
• [38] Silva L.J.G., Pereira A.M.P.T., Meisel L.M., Lino C.M., Pena A., A one-year follow-up analysis of antidepressants in Portuguese wastewaters: Occurrence and fate, seasonal influence and risk assessment, Science of the Total Environment, Vol. 490, 2014, 279–287.
• [39] Sousa M.A., Goncalves C., Cunha E., Hajslova J., Alpendurada M.F., Cleanup strategies and advantages in the determination of several therapeutic classes of pharmaceuticals in wastewater samples by SPE-LC-MS/MS, Analytical and Bioanalytical Chemistry, Vol. 399, 2011, 807–822.
• [40] Snyder S.A., Occurrence, treatment and toxicological relevance of EDCs and pharmaceuticals in water, Ozone: Science & Engineering Vol. 30, 2008, 65–69.
• [41] Subedi B., Kannan K., Occurrence and fate of select psychoactive pharmaceuticals and antihypertensives in two wastewater treatment plants in New York State, USA, Science of the Total Environment, Vol. 514, 2015, 273–280.
• [42] Tarcomnicu I., van Nuijs A.L.N., Simons W., Bervoets L., Blust R., Jorens P.G., Neels H., Covaci A., Simultaneous determination of 15 top-prescribed pharmaceuticals and their metabolites in influent wastewater by reversed-phase liquid chromatography coupled to tandem mass spectrometry, Talanta, Vol. 83, 2011, 795–803.
• [43] Togola A., Budzinski H., Multi-residue analysis of pharmaceutical compounds in aqueous samples, Journal of Chromatography A, Vol. 1177, 2008, 150–158.
• [44] Valcarcel Y., Alonso S.G., Rodriguez-Gil J.L., Gil A., Catala M., Detection of pharmaceutically active compounds in the rivers and tap water of the Madrid Region (Spain) and potential ecotoxicological risk, Chemosphere, Vol. 84, 2011, 1336–1348.
• [45] Vasskog T., Anderssen T., Pedersen-Bjergaard S., Kallenborn R., Jensen E., Occurrence of selective serotonin reuptake inhibitors in sewage and receiving waters at Spitsbergen and in Norway, Journal of Chromatography A, Vol. 1185, 2008, 194–205.
• [46] Vasskog T., Berger U., Samuelsen P.J., Kallenborn R., Jensen R., Selective serotonin reuptake inhibitors in sewage influents and effluents from TromsØ, Norway, Journal of Chromatography A, Vol. 1115, 2006, 187–195.
• [47] Vergeynst L., Haeck A., De Wispelaere P., Van Langenhove H., Demeestere K., Multiresidue analysis of pharmaceuticals in wastewater by liquid chromatography-magnetic sector mass spectrometry: Method quality assessment and application in a Belgian case study, Chemosphere, Vol. 119, 2015, S2–S8.
• [48] Verlicchi P., Al. Aukidy M., Zambello E., Occurrence of pharmaceutical compounds in urban wastewater: Removal, mass load and environmental risk after a secondary treatment-A review, Science of the Total Environment, Vol. 429, 2012, 123–155.
• [49] Węgrzyn A., Machura M., Żabczyk S., Possibilities for Removal of Contrast Agents from Wastewater, Ochrona Srodowiska, Vol. 37(1), 2015, 55–63.
• [50] Writer J.H., Ferrer I., Barber L.B., Thurman E.M., Widespread occurrence of neuroactive pharmaceuticals and metabolites in 24 Minnesota rivers and wastewaters, Science of the Total Environment, Vol. 461–462, 2013, 519–527.
• [51] Wu C., Witter J.D., Spongberg A.L., Czajkowski K.P., Occurrence of selected pharmaceuticals in an agricultural landscape, western Lake Erie basin, Water Research, Vol. 43, 2009, 3407–3416.
• [52] Yuan S., Jiang X., Xia X., Zhang H., Zheng S., Detection, occurrence and fate of 22 psychiatric pharmaceuticals in psychiatric hospital and municipal wastewater treatment plants in Beijing, Chemosphere, Vol. 90, 2013, 2520–2525.
• [53] Zejc A., Gorczyca M., Chemia Leków, Warszawa, PZWL, 2009.